Federico Simonetti

509 total citations
16 papers, 188 citations indexed

About

Federico Simonetti is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Federico Simonetti has authored 16 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 4 papers in Hematology. Recurrent topics in Federico Simonetti's work include Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Federico Simonetti is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Federico Simonetti collaborates with scholars based in Italy, Canada and United States. Federico Simonetti's co-authors include Andrea Malaspina, Dario Alimonti, Simone Tonietti, Enrico Capochiani, Monica Bocchia, Annarosa Cuccaro, Mauro Ceroni, C. Uggetti, Marino Celano and Nicola Di Renzo and has published in prestigious journals such as Blood, Neurology and Quality of Life Research.

In The Last Decade

Federico Simonetti

14 papers receiving 183 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federico Simonetti Italy 8 79 40 37 32 23 16 188
Fatih Azık Türkiye 10 131 1.7× 13 0.3× 19 0.5× 60 1.9× 23 1.0× 51 271
Alex Sternberg United Kingdom 6 42 0.5× 19 0.5× 16 0.4× 29 0.9× 22 1.0× 8 125
Jubran Alqanatish Saudi Arabia 6 18 0.2× 27 0.7× 34 0.9× 14 0.4× 12 0.5× 22 179
Melissa Tesher United States 8 82 1.0× 11 0.3× 54 1.5× 16 0.5× 9 0.4× 19 180
Koray Yalçın Türkiye 7 43 0.5× 10 0.3× 32 0.9× 17 0.5× 23 1.0× 29 170
Elena Mastrodicasa Italy 6 39 0.5× 9 0.2× 21 0.6× 15 0.5× 29 1.3× 11 115
Anna Panasiuk Poland 10 61 0.8× 13 0.3× 9 0.2× 18 0.6× 42 1.8× 35 248
Alessandro Cattoni Italy 9 39 0.5× 11 0.3× 7 0.2× 32 1.0× 10 0.4× 43 217
Aldo Naselli Italy 9 38 0.5× 7 0.2× 35 0.9× 31 1.0× 12 0.5× 28 210
Santosh Rai India 8 13 0.2× 22 0.6× 13 0.4× 12 0.4× 32 1.4× 63 252

Countries citing papers authored by Federico Simonetti

Since Specialization
Citations

This map shows the geographic impact of Federico Simonetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Simonetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Simonetti more than expected).

Fields of papers citing papers by Federico Simonetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Simonetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Simonetti. The network helps show where Federico Simonetti may publish in the future.

Co-authorship network of co-authors of Federico Simonetti

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Simonetti. A scholar is included among the top collaborators of Federico Simonetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Simonetti. Federico Simonetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cencini, Emanuele, Ilaria Romano, Lara Mannelli, et al.. (2023). Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network). Annals of Hematology. 102(4). 841–849. 1 indexed citations
2.
Antonioli, Elisabetta, Gabriele Buda, Alessandro Gozzetti, et al.. (2023). Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network. Frontiers in Oncology. 13. 1162990–1162990. 2 indexed citations
3.
Canale, Maria Laura, Andrea Camerini, Francesco Orso, et al.. (2022). Modello organizzativo e di un percorso clinico per la gestione cardiologica ambulatoriale del paziente oncologico: una proposta congiunta ANMCO e AIOM Toscana. Giornale italiano di cardiologia. 23(6). 437–443.
4.
Cencini, Emanuele, Benedetta Puccini, Federico Simonetti, et al.. (2022). Pixantrone in patients with relapsed/refractory diffuse large B‐cell lymphoma: A real‐life, retrospective, multicenter trial on behalf of the “RTL” (Regional Tuscan Lymphoma network). European Journal Of Haematology. 108(5). 383–390. 1 indexed citations
5.
Canale, Maria Laura, Jacopo Del Meglio, Federico Simonetti, et al.. (2022). Case Series: Recovery of Chemotherapy-Related Acute Heart Failure by the Combined Use of Sacubitril Valsartan and Wearable Cardioverter Defibrillator: A Novel Winning Combination in Cardio-Oncology. Frontiers in Cardiovascular Medicine. 9. 801143–801143. 3 indexed citations
7.
Cencini, Emanuele, Ilaria Romano, Federico Simonetti, et al.. (2021). Ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a real-life, retrospective, multicenter trial on behalf of the "RTL" (regional Tuscan lymphoma network).. PubMed. 11(4). 373–383. 5 indexed citations
8.
Capochiani, Enrico, Bruno Frediani, Giorgio Iervasi, et al.. (2020). Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol. Frontiers in Medicine. 7. 466–466. 42 indexed citations
9.
10.
Graffigna, Guendalina, Massimo Breccia, Enrico Capochiani, et al.. (2017). Recovering from chronic myeloid leukemia: the patients’ perspective seen through the lens of narrative medicine. Quality of Life Research. 26(10). 2739–2754. 20 indexed citations
11.
Lambelet, Paola, Carlo Tascini, Federico Simonetti, et al.. (2017). Oral gentamicin therapy for Carbapenem-resistant Klebsiella pneumoniae gut colonization in hematologic patients: a single center experience.. PubMed. 40(3). 161–164. 10 indexed citations
12.
Zaja, Francesco, Wilma Barcellini, Silvia Cantoni, et al.. (2016). Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study. American Journal of Hematology. 91(5). E293–5. 33 indexed citations
13.
Rosti, Giovanni, Mario Petrini, Alberto Bosi, et al.. (2016). Management of anaemia in oncohaematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study. Therapeutic Advances in Medical Oncology. 9(1). 22–32. 9 indexed citations
14.
Scappini, Barbara, Giacomo Gianfaldoni, F Caracciolo, et al.. (2012). Cytarabine and clofarabine after high‐dose cytarabine in relapsed or refractory AML patients. American Journal of Hematology. 87(12). 1047–1051. 21 indexed citations
15.
Benedetti, E., Federico Simonetti, F Caracciolo, et al.. (2009). Early Diagnosis of Neutropenic Enterocolitis by Ultrasound Sonography.. Blood. 114(22). 4742–4742. 1 indexed citations
16.
Ceroni, Mauro, Tino Emanuele Poloni, Simone Tonietti, et al.. (2000). Migraine with aura and white matter abnormalities: Notch3 mutation. Neurology. 54(9). 1869–1871. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026